Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: Potential importance of regional differences in H. pylori-associated disease

Journal of Clinical Microbiology

Volumn 46, Issue 5, 2008, Pages 1774-1779

  Hussein, Nawfal R ^a,b   Mohammadi, Marjan ^c   Talebkhan, Yeganeh ^c   Doraghi, Masoumeh ^c   Letley, Darren P ^a   Muhammad, Merdan K ^a   Argent, Richard H ^a   Atherton, John C ^a,d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF DUHOK   (Iraq)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ADULT; ALLELE; ARTICLE; CAGA GENE; CANCER INCIDENCE; CONTROLLED STUDY; DUPA GENE; DYSPEPSIA; ENVIRONMENTAL FACTOR; GENE; HELICOBACTER PYLORI; HOST; HUMAN; HUMAN TISSUE; IRAN; IRAQ; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; STOMACH ULCER; VACA GENE; VIRUS VIRULENCE;

ADOLESCENT; ADULT; ALLELES; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; IRAQ; MIDDLE AGED; PEPTIC ULCER; POLYMORPHISM, GENETIC; VIRULENCE FACTORS;

HELICOBACTER PYLORI;

EID: 43249096044     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01737-07     Document Type: Article

References (38)

1. Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Bukanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:37-53.
2. Arents, N. L., A. A. van Zwet, J. C. Thijs, A. M. Kooistra-Smid, K. R. van Slochteren, J. E. Degener, J. H. Kleibeuker, and L. J. van Doorn. 2001. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am. J. Gastroenterol. 96:2603-2608.
3. Argent, R. H., A. Burette, V. Y. M. Deyi, and J. C. Atherton. 2007. The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin. Infect. Dis. 45:1204-1206.
4. Argent, R. H., M. Kidd, R. J. Owen, R. J. Thomas, M. C. Limb, and J. C. Atherton. 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127:514-523.
5. Argent, R. H., Y. Zhang, and J. C. Atherton. 2005. Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J. Clin. Microbiol. 43:791-795.
6. Atherton, J. 2006. The pathogenesis of H. pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. Mech. Dis. 1:63-96.
7. Atherton, J. C. 1998. H. pylori virulence factors. Br. Med. Bull. 54:105-120.
8. Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771- 17777.
9. Azuma, T., A. Yamakawa, S. Yamazaki, K. Fukuta, M. Ohtani, Y. Ito, M. Dojo, Y. Yamazaki, and M. Kuriyama. 2002. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 186:1621-1630.
10. Globocan, IARC. 2002. Cancer map: male stomach cancer, age-standardized incidence rate per 100,000. http:/www-dep.iarc.fr/2007/05/30.
11. Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99:14428-14433.
12. Holcombe, C. 1992. Helicobacter pylori: the African enigma. Gut 33:429-431.
13. Iwamoto, H., D. M. Czajkowsky, T. L. Cover, G. Szabo, and Z. Shao. 1999. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett. 450:101-104.
14. Kersulyte, D., A. K. Mukhopadhyay, B. Velapatino, W. Su, Z. Pan, C. Garcia, V. Hernandez, Y. Valdez, R. S. Mistry, R. H. Gilman, Y. Yuan, H. Gao, T. Alarcon, M. Lopez-Brea, G. Balakrish Nair, A. Chowdhury, S. Datta, M. Shirai, T. Nakazawa, R. Ally, I. Segal, B. C. Wong, S. K. Lam, F. O. Olfat, T. Boren, L. Engstrand, O. Torres, R. Schneider, J. E. Thomas, S. Czinn, and D. E. Berg. 2000. Differences in genotypes of Helicobacter pylori from different human populations. J. Bacteriol. 182:3210-3218.
15. Kidd, M., A. J. Lastovica, J. C. Atherton, and J. A. Louw. 1999. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut 45:499-502.
16. Lu, H., P. I. Hsu, D. Y. Graham, and Y. Yamaoka. 2005. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128:833-848.
17. Maeda, S., K. Ogura, H. Yoshida, F. Kanai, T. Ikenoue, N. Kato, Y. Shiratori, and M. Omata. 1998. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42:338-343.
18. Marshall, B. J., and J. R. Warren. 2001. One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease, p. 19-24. In H. L. T. Mobley, G. L. Mendz, and S. L. Hazell. (ed.), Helicobacter pylori: physiology and genetics. ASM Press, Washington, DC.
19. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315.
20. McClain, M. S., P. Cao, H. Iwamoto, A. D. Vinion-Dubiel, G. Szabo, Z. Shao, and T. L. Cover. 2001. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 183:6499-6508.
21. Nouraie, M., A. Pourshams, F. Kamangar, M. Sotoudeh, M. H. Derakhshan, M. R. Akbari, H. Fakheri, M. J. Zahedi, K. Caldwell, C. C. Abnet, P. R. Taylor, R. Malekzadeh, and S. M. Dawsey. 2004. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J. Gastroenterol. 10:2544-2546.
22. Peek, R. M., Jr., and M. J. Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
23. Rhead, J. L., D. P. Letley, M. Mohammadi, N. Hussein, M. A. Mohagheghi, M. Eshagh Hosseini, and J. C. Atherton. 2007. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133:926-936.
24. Rokkas, T., S. Ladas, C. Liatsos, E. Petridou, G. Papatheodorou, S. Theocharis, A. Karameris, and S. Raptis. 1999. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci. 44:487-493.
25. Rudi, J., C. Kolb, M. Maiwald, D. Kuck, A. Sieg, P. R. Galle, and W. Stremmel. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36:944-948.
26. Sadjadi, A., R. Malekzadeh, M. H. Derakhshan, A. Sepehr, M. Nouraie, M. Sotoudeh, A. Yazdanbod, B. Shokoohi, A. Mashayekhi, S. Arshi, A. Majidpour, M. Babaei, A. Mosavi, M. A. Mohagheghi, and M. Alimohammadian. 2003. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int. J. Cancer 107:113-118.
27. Sadjadi, A., M. Nouraie, M. A. Mohagheghi, A. Mousavi-Jarrahi, R. Malekezadeh, and D. M. Parkin. 2005. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac. J. Cancer Prev. 6:359-363.
28. Saribasak, H., B. A. Salih, Y. Yamaoka, and E. Sander. 2004. Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J. Clin. Microbiol. 42:1648-1651.
29. Selbach, M., S. Moese, C. R. Hauck, T. F. Meyer, and S. Backert. 2002. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:6775-6778.
30. Stein, M., F. Bagnoli, R. Halenbeck, R. Rappuoli, W. J. Fantl, and A. Covacci. 2002. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:971-980.
31. Stephens, J. C., J. A. Stewart, A. M. Folwell, and B. J. Rathbone. 1998. Helicobacter pylori cagA status, vacA genotypes and ulcer disease. Eur. J. Gastroenterol. Hepatol. 10:381-384.
32. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
33. Tsutsumi, R., H. Higashi, M. Higuchi, M. Okada, and M. Hatakeyama. 2003. Attenuation of Helicobacter pylori CagA X SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278:3664-3670.
34. van Doorn, L. J., C. Figueiredo, F. Megraud, S. Pena, P. Midolo, D. M. Queiroz, F. Carneiro, B. Vanderborght, M. D. Pegado, R. Sanna, W. De Boer, P. M. Schneeberger, P. Correa, E. K. Ng, J. Atherton, M. J. Blaser, and W. G. Quint. 1999. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116:823-830.
35. van Doorn, L. J., C. Figueiredo, R. Sanna, S. Pena, P. Midolo, E. K. Ng, J. C. Atherton, M. J. Blaser, and W. G. Quint. 1998. Expanding allelic diversity of Helicobacter pylori vacA. J. Clin. Microbiol. 36:2597-2603.
36. Whitfield, J. 2003. The ulcer bug: gut reaction. Nature 423:583-584.
37. Xiang, Z., S. Censini, P. F. Bayeli, J. L. Telford, N. Figura, R. Rappuoli, and A. Covacci. 1995. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:94-98.
38. Yavari, P., T. G. Hislop, C. Bajdik, A. Sadjadi, M. Nouraie, M. Babai, and R. Malekzadeh. 2006. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac. J. Cancer Prev. 7:86-90.